retatrutide phase 3 results Trial Are IN‼️📊 #retatrutide #peptides Today, we shared new data

A small observational study published in JCI Insight (2022) examined individuals with obesity receiving semaglutide who reported reductions in alcohol intake, though the relationship to weight loss requires further investigation in controlled trials

Key Takeaways Market Scale : The GLP-1 market is projected to exceed $200 billion by 2033, making it the most significant therapeutic class for capital allocation in the next decade

Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats

That positioning shapes the program design